Clinical Trial: An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033026) titled 'An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.' on June 13.

Brief Summary: A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer CRC (Colorectal Cancer) Cancer Cachexia

Intervention: DRUG: NGM120 Q4W

NGM120 given subcutaneously every 4 weeks

DRUG: NGM120 Q8W

NGM120 given subcutaneously every 8 weeks

DRUG: Placebo given

Placebo given subcutan...